EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Challenges of in vitro modelling of liver fibrosis

Patricia Ros-Tarraga, Estela Villanueva-Badenas, Estela Sanchez-Gonzalez, Gloria Gallego-Ferrer, M Teresa Donato, Laia Tolosa

Frontiers in Cell and Developmental Biology · 30.04.2025 · 13

DOI: 10.3389/fcell.2025.1567916 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 30.04.2025. Verfasst von Patricia Ros-Tarraga und 5 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Hepatology Unit, Health Research Institute La Fe (IISLAFE), Valencia, Spain. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis has been proposed as the most important predictive indicator affecting prognosis of patients with chronic liver disease. It is defined by an abnormal accumulation of extracellular matrix components that results from necrotic and inflammatory processes and eventually impairs organ function. With no approved therapy, comprehensive cellular models directly derived from patient’s cells are necessary to understand the mechanisms behind fibrosis and the response to anti-fibrotic therapies. Primary human cells, human hepatic cell lines and human stem cells-derived hepatic stellate-like cells have been widely used for studying fibrosis pathogenesis. In this paper, we depict the cellular crosstalk and the role of extracellular matrix during fibrosis pathogenesis and summarize different in vitro models from simple monolayers to multicellular 3D cultures used to gain deeper mechanistic understanding of the disease and the therapeutic response, discussing their major advantages and disadvantages for liver fibrosis modelling.

Schlagwörter

Stichwörter der Autor:innen

3D modelsextracellular matrixin vitro systemsliver fibrosistherapies

Autor:innen und Institutionen

  • Experimental Hepatology Unit, Health Research Institute La Fe (IISLAFE), Valencia, Spain.
  • Faculty of Medicine and Dentistry, Department of Biochemistry and Molecular Biology, University of Valencia, Valencia, Spain.
  • Center for Biomaterials and Tissue Engineering (CBIT), Universitat Politècnica de València, Valencia, Spain.
  • Biomedical Research Networking Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Carlos III Health Institute, Valencia, Spain.
  • Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute, Madrid, Spain.

Zitieren

APA

Ros-Tarraga, P., Villanueva-Badenas, E., Sanchez-Gonzalez, E., Gallego-Ferrer, G., Donato, M. T., & Tolosa, L. (2025). Challenges of in vitro modelling of liver fibrosis. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1567916

Vancouver

Ros-Tarraga P, Villanueva-Badenas E, Sanchez-Gonzalez E, Gallego-Ferrer G, Donato MT, Tolosa L. Challenges of in vitro modelling of liver fibrosis. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1567916

BibTeX
@article{RosTarraga2025,
  author = {Ros-Tarraga, Patricia and Villanueva-Badenas, Estela and Sanchez-Gonzalez, Estela and Gallego-Ferrer, Gloria and Donato, M Teresa and Tolosa, Laia},
  title = {Challenges of in vitro modelling of liver fibrosis},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fcell.2025.1567916}
}
Kostenlos starten →